Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.

Knight JS, Sharma N, Robertson ES.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18562-6. Epub 2005 Dec 13.

2.

Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.

Bajaj BG, Murakami M, Cai Q, Verma SC, Lan K, Robertson ES.

J Virol. 2008 Apr;82(8):4082-90. doi: 10.1128/JVI.02500-07. Epub 2008 Feb 6.

3.

Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.

Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES.

J Virol. 2009 May;83(9):4652-69. doi: 10.1128/JVI.02408-08. Epub 2009 Feb 25.

5.

EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.

Jha HC, Lu J, Saha A, Cai Q, Banerjee S, Prasad MA, Robertson ES.

J Virol. 2013 Nov;87(22):12121-38. doi: 10.1128/JVI.02379-13. Epub 2013 Aug 28.

6.

Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.

Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES.

PLoS Pathog. 2011 Feb 10;7(2):e1001275. doi: 10.1371/journal.ppat.1001275.

7.

Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.

Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES.

Virology. 2009 Jun 5;388(2):236-47. doi: 10.1016/j.virol.2009.03.027. Epub 2009 Apr 24.

8.

Targeting retinoblastoma protein for degradation by proteasomes.

Ying H, Xiao ZX.

Cell Cycle. 2006 Mar;5(5):506-8. Epub 2006 Mar 1.

PMID:
16552188
9.

Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C.

Sharma N, Knight JS, Robertson ES.

Virology. 2006 Mar 15;346(2):379-84. Epub 2005 Dec 20.

10.

Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.

Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES.

J Virol. 2018 Aug 29;92(18). pii: e00663-18. doi: 10.1128/JVI.00663-18. Print 2018 Sep 15.

12.

SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen.

Knight JS, Sharma N, Robertson ES.

Mol Cell Biol. 2005 Mar;25(5):1749-63.

13.

E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.

Saha A, Lu J, Morizur L, Upadhyay SK, Aj MP, Robertson ES.

PLoS Pathog. 2012;8(3):e1002573. doi: 10.1371/journal.ppat.1002573. Epub 2012 Mar 15.

14.
16.

Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.

Cai Q, Guo Y, Xiao B, Banerjee S, Saha A, Lu J, Glisovic T, Robertson ES.

PLoS Pathog. 2011 Dec;7(12):e1002418. doi: 10.1371/journal.ppat.1002418. Epub 2011 Dec 8.

17.

EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.

Banerjee S, Lu J, Cai Q, Sun Z, Jha HC, Robertson ES.

PLoS Pathog. 2014 Aug 14;10(8):e1004304. doi: 10.1371/journal.ppat.1004304. eCollection 2014 Aug.

18.

EBNA3C coactivation with EBNA2 requires a SUMO homology domain.

Rosendorff A, Illanes D, David G, Lin J, Kieff E, Johannsen E.

J Virol. 2004 Jan;78(1):367-77.

19.

Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.

Skalska L, White RE, Parker GA, Turro E, Sinclair AJ, Paschos K, Allday MJ.

PLoS Pathog. 2013 Feb;9(2):e1003187. doi: 10.1371/journal.ppat.1003187. Epub 2013 Feb 21. Erratum in: PLoS Pathog. 2013 Mar; 9(3): doi:10.1371/annotation/2c4b89c1-6d4a-4bf3-9467-9367227d7e74. Turro, Ernest [added].

20.

Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.

Jha HC, A J MP, Saha A, Banerjee S, Lu J, Robertson ES.

J Virol. 2014 Apr;88(7):3776-88. doi: 10.1128/JVI.03568-13. Epub 2014 Jan 15.

Supplemental Content

Support Center